| Literature DB >> 27590469 |
Mary J Homer1, Robert Raulli2, Andrea L DiCarlo-Cohen3, John Esker2, Chad Hrdina4, Bert W Maidment3, Brian Moyer2, Carmen Rios3, Francesca Macchiarini3, Pataje G Prasanna5, Lynne Wathen2.
Abstract
The United States Department of Health and Human Services (HHS) is fully committed to the development of medical countermeasures to address national security threats from chemical, biological, radiological, and nuclear agents. Through the Public Health Emergency Medical Countermeasures Enterprise, HHS has launched and managed a multi-agency, comprehensive effort to develop and operationalize medical countermeasures. Within HHS, development of medical countermeasures includes the National Institutes of Health (NIH), (led by the National Institute of Allergy and Infectious Diseases), the Office of the Assistant Secretary of Preparedness and Response/Biomedical Advanced Research and Development Authority (BARDA); with the Division of Medical Countermeasure Strategy and Requirements, the Centers for Disease Control and Prevention, and the Food and Drug Administration as primary partners in this endeavor. This paper describes various programs and coordinating efforts of BARDA and NIH for the development of medical countermeasures for radiological and nuclear threats. © World Health Organisation 2016. All rights reserved. The World Health Organization has granted Oxford University Press permission for the reproduction of this article.Entities:
Mesh:
Year: 2016 PMID: 27590469 PMCID: PMC6280724 DOI: 10.1093/rpd/ncw226
Source DB: PubMed Journal: Radiat Prot Dosimetry ISSN: 0144-8420 Impact factor: 0.972